Mutations in Spliceosomal Genes PPIL1 and PRP17 Cause Neurodegenerative Pontocerebellar Hypoplasia with Microcephaly

剪接体基因PPIL1和PRP17的突变导致神经退行性脑桥小脑发育不全伴小头畸形

阅读:5
作者:Guoliang Chai,Alice Webb,Chen Li,Danny Antaki,Sangmoon Lee,Martin W Breuss,Nhi Lang,Valentina Stanley,Paula Anzenberg,Xiaoxu Yang,Trevor Marshall,Patrick Gaffney,Klaas J Wierenga,Brian Hon-Yin Chung,Mandy Ho-Yin Tsang,Lynn S Pais,Alysia Kern Lovgren,Grace E VanNoy,Heidi L Rehm,Ghayda Mirzaa,Eyby Leon,Jullianne Diaz,Alexander Neumann,Arnout P Kalverda,Iain W Manfield,David A Parry,Clare V Logan,Colin A Johnson,David T Bonthron,Elizabeth M A Valleley,Mahmoud Y Issa,Sherif F Abdel-Ghafar,Mohamed S Abdel-Hamid,Patricia Jennings,Maha S Zaki,Eamonn Sheridan,Joseph G Gleeson

Abstract

Autosomal-recessive cerebellar hypoplasia and ataxia constitute a group of heterogeneous brain disorders caused by disruption of several fundamental cellular processes. Here, we identified 10 families showing a neurodegenerative condition involving pontocerebellar hypoplasia with microcephaly (PCHM). Patients harbored biallelic mutations in genes encoding the spliceosome components Peptidyl-Prolyl Isomerase Like-1 (PPIL1) or Pre-RNA Processing-17 (PRP17). Mouse knockouts of either gene were lethal in early embryogenesis, whereas PPIL1 patient mutation knockin mice showed neuron-specific apoptosis. Loss of either protein affected splicing integrity, predominantly affecting short and high GC-content introns and genes involved in brain disorders. PPIL1 and PRP17 form an active isomerase-substrate interaction, but we found that isomerase activity is not critical for function. Thus, we establish disrupted splicing integrity and "major spliceosome-opathies" as a new mechanism underlying PCHM and neurodegeneration and uncover a non-enzymatic function of a spliceosomal proline isomerase.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。